DRTS as reported
- Net Income
- −$43M
Net Income · +56% year on year · trailing twelve months to FY2025
- Free Cash Flow
- −$33M
Free Cash Flow · +122% year on year · trailing twelve months to FY2025
- EPS
- −$0.53
EPS · −21% year on year · trailing twelve months to FY2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net Income | −$43M | +56% | FY2025 |
| EPS | −$0.53 | −21% | FY2025 |
| ROE | −55% | n/a | FY2025 |
| ROA | −40% | n/a | FY2025 |
| Free Cash Flow | −$33M | +122% | FY2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Alpha Tau Medical Ltd. (DRTS) - Net IncomeNet IncomeAlpha Tau Medical Ltd. (DRTS)
Biotechnology
The closest names by size in the same industry